1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Home blood glucose monitoring.
- Who it may be relevant to
- Registry conditions: Gestational Diabetes, Treatment Adherence. Basic parameters: 18 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Malaysia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
1 Versus 2 Hours Post Meal Self Monitoring Blood Glucose in Gestational Diabetes Mellitus on Treatment-A Prospective Randomised Controlled Trial
Overview
A study to compare between 1 and 2 hours post meal blood glucose monitoring in patients with Gestational Diabetes Mellitus requiring treatment.
Detailed description
This study involves all pregnant women who attended our antenatal clinic with Gestational Diabetes Mellitus requiring treatment. They will be randomised to either 1 or 2 hours post meal self blood glucose monitoring. The blood sugar profile is a staggered 7 points. They are followed up in the research clinic until delivery.
Interventions
- Other Home blood glucose monitoring
Self monitoring of capillary blood glucose
Primary outcome measures
- Mode of delivery [Time frame: from point of randomization to birth of the neonate]
- Gestational age [Time frame: from point of randomization to birth of the neonate]
- Fetal weight [Time frame: from point of randomization to birth of the neonate]
Secondary outcome measures (2)
- Maternal complications [Time frame: from point of randomization to birth of the neonate]
- perinatal complications [Time frame: from point of randomization to birth of the neonate]
Eligibility criteria
Inclusion criteria
- Gestational diabetes diagnosed based on National Institute for Health and Care Excellence guideline
- requiring treatment either with metformin alone or combined with insulin
Exclusion criteria
- type 1 and 2 diabetes
- bad obstetrics history
- underlying medical disorders such as Systemic Lupus Erythematosus
- fetal anomaly
- delivery elsewhere
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Other
Study locations
Malaysia · 1 center
- UKM Medical Center — Kuala Lumpur
Identifiers
NCT: NCT05326204 · FF-2022-002